Comparison of dosimetry and toxicities between postoperative fixed-field intensity-modulated radiotherapy and image-guided radiation therapy/volumetric modulated arc therapy for cervical cancer
Tu Jiannan, Zuohelaguli·Mutalifu, Zhang Jie, Ye Weijun , Jin Hua
Department of Gynecological Radiotherapy Two Ward,Affiliated Tumor Hospital,Xinjiang Medical University,Urumqi 830011,China (Tu JN,Zuohelaguli·M,Zhang J,Jin H);
Department of Radiotherapy,Affiliated Tumor Hospital,Sun Yat-sen University,Guangzhou,510000,China (Ye WJ)
Objective To compare the dosimetry and toxicities between postoperative fixed-field intensity-modulated radiotherapy (FF-IMRT) and image-guided radiation therapy/volumetric modulated arc therapy (IGRT-VMAT) for cervical cancer. Methods A total of seventy patients with stage Ⅰ b—Ⅱ a postoperative cervical cancer who had high risk factors,were divided into FF-IMRT (FF-IMRT group,n=35) and IGRT-VMAT (IGRT-VMAT group,n=35),to compare the difference of target dose and adverse reaction between the two groups. Results In the IGRT-VMAT group,the interfractional setup errors in the x,y,and z axes were (0.25±0.14) cm,(0.26±0.16) cm,and (0.24±0.18) cm,respectively;the intrafractional setup errors in the x,y,and z axes were (0.1±0.09) cm,(0.12±0.09) cm,and (0.11±0.09) cm,respectively;the margins in the x,y,and z axes were 0.75 cm,0.84 cm,and 0.78 cm,respectively. Under the same dosimetric conditions,the IGRT-VMAT group was superior to the FF-IMRT group in terms of conformity index,treatment time,and number of monitor units (P=0.000). The Dmean and volume receiving high-dose irradiation for the bladder,rectum,and small intestine were significantly lower in the IGRT-VMAT group than in the FF-IMRT group (P=0.000). Compared with the FF-IMRT group,the IGRT-VMAT group had a significantly reduced incidence of acute and chronic gastrointestinal,urinary,and hematologic toxicities (P<0.05). Conclusions IGRT-VMAT can correct setup error online,shorten the treatment time,reduce the dose to organs at risk,and alleviate acute and chronic toxicities,and is especially suitable for patients with postoperative small bowel position changes.
Tu Jiannan,Zuohelaguli·Mutalifu,Zhang Jie et al. Comparison of dosimetry and toxicities between postoperative fixed-field intensity-modulated radiotherapy and image-guided radiation therapy/volumetric modulated arc therapy for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(4): 410-413.
[1] Kim JH,Choi JH,Ki EY,et al. Incidence and risk factors of lower extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage Ⅰ to stage ⅡA cervical cancer[J].Int J Gynecol Cancer,2012,22(4):686-691.DOI:10.1097/IGC.0b013e3182466950
[2] Landoni F,Maneo A,Colombo A,et al. Randomised study of radical surgery versus radiotherapy for stage Ⅰ b Ⅱ a cervical cancer[J].Lancet,1997,350(9077):535-540.DOI:10.1016/S0140-6736(97)02250-2
[3] Mabuchi S,Morishige KI,Isohashi F,et al. Postoperative concurrent nedaplatin based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors[J].Gynecol Oncol,2009,115(3):482-487.DOI:10.1016/j.ygyno.2009.09.002
[4] Sehouli J,Runnebaum IB,Fotopoulou C,et al. A randomized phase Ⅲ adjuvant study in high-risk cervical cancer:simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R):a NOGGO-AGO-intergroup study[J].Ann Oncol,2012,23(9):2259-2264.DOI:10.1093/annonc/mdr628
[5] Zhang G,Fu C,Zhang Y,et al. Extended field intensity modulated radiotherapy and concurrent cisplatin based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases:a retrospective review in a single institution[J].Int J Gynecol Cancer,2012,22(7):1220-1225.DOI:10.1097/IGC.0b013e3182643b7c
[6] Stroom JC,Heijmen BJM.Geometrical uncertainties,radiotherapy planning margins,and the ICRU-62 report[J].Radiother Oncol,2002,64(1):75-83.DOI:10.1016/S0167-8140(02)00140-8
[7] van Herk M.Errors and margins in radiotherapy[J].Semin Radiat Oncol,2004,14(1):52-64.DOI:10.1053/j.semradonc.2003.10.003
[8] 滕建建,徐利明,全红.宫颈癌IMRT中两种计划方法的比较[J].肿瘤预防与治疗,2010,23(3):231-233.DOI:10.3969/j.issn.1674-0904.2010.03.015.
Teng JJ,Xu LM,Quan H.A comparison between two different IMRT planning methods for cervix cancer[J].J Cancer Control Treat,2010,23(3):231-233.DOI:10.3969/j.issn.1674-0904.2010.03.015
[9] 刘翔宇,柳先锋,何亚男,等.宫颈癌放疗中的快速旋转调强计划和调强计划比较[J].中华放射医学与防护杂志,2011,31(3):326-328.DOI:10.3760/cma.j.issn.0254-5098.2011.03.019.
Liu XY,Liu XF,He YN,et al. Comparison of RapidArc plans and fixed field intensity modulated radiotherapy planning in cervical cancer radiotherapy[J].Chin J Radiol Med Prot,2011,31(3):326-328.DOI:10.3760/cma.j.issn.0254-5098.2011.03.019.
[10] 杨国姿,潘振宇,夏文明,等.容积旋转调强与固定野动态调强在宫颈癌术后放疗的剂量学比较[J].中华放射医学与防护杂志,2014,34(1):37-40.DOI:10.3760/cma.j.issn.0254-5098.2014.01.010.
Yang GZ,Pan ZY,Xia WM,et al. Dosimetric comparison and clinical application of RapidArc and intensity-modulated radiotherapy for postoperative radiotherapy of cervical cancer[J].Chin J Radiol Med Prot,2014,34(1):37-40.DOI:10.3760/cma.j.issn.0254-5098.2014.01.010.
[11] 刘艳,佐合拉古丽·木塔力甫,张洁,等.分次内和分次间摆位误差在宫颈自适应放疗中的研究[J].现代肿瘤医学,2015,23(24):3626-3629.DOI:10.3969/j.issn.1672-4992.2015.24.026.
Liu Y,Zuohelaguli·Mutalifu,Zhang J,et al. The study of intra-and inter-fractionalset-up errorsin the cervical adaptive radiotherapy[J].J Mod Oncol,2015,23(24):3626-3629.DOI:10.3969/j.issn.1672-4992.2015.24.026.
[12] Huang B,Fang Z,Huang Y,et al. A dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction vs. 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer[J].Br J Radiol,2014,87(1039):20140183.DOI:10.1259/bjr.20140183.
[13] Nguyen K,Cummings D,Lanza VC,et al. A dosimetric comparative study:volumetric modulated arc therapy vs. intensity-modulated radiation therapy in the treatment of nasal cavity carcinomas[J].Med Dosim,2013,38(3):225-232.DOI:10.1016/j.meddos.2013.01.006.
2017, Vol. 26 
